These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 1595513)

  • 21. Diabetes responsive to intravenous but not subcutaneous insulin: effectiveness of aprotinin.
    Freidenberg GR; White N; Cataland S; O'Dorisio TM; Sotos JF; Santiago JV
    N Engl J Med; 1981 Aug; 305(7):363-8. PubMed ID: 7019707
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Technology of pre-programmable insulin delivery systems: continuous subcutaneous insulin infusion.
    Pickup JC; Keen H; Parsons JA; Alberti KG
    Horm Metab Res Suppl; 1979; (8):49-51. PubMed ID: 395089
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Insulin therapy by subcutaneous infusion using a portable pump. A simple method to stabilize brittle diabetics (author's transl)].
    Berger W; Schwarz U; Kaegi E; Keller U; Viollier E
    Schweiz Rundsch Med Prax; 1979 Dec; 68(49):1620-9. PubMed ID: 397488
    [No Abstract]   [Full Text] [Related]  

  • 24. [Estimation of daily insulin requirement in diabetes using intravenous infusion of insulin].
    Lawecki J; Krzymień J
    Pol Tyg Lek; 1979 Jan; 34(3):81-4. PubMed ID: 424341
    [No Abstract]   [Full Text] [Related]  

  • 25. The artificial beta cell (Biostator) in the adjustment of instable diabetics--results after 20 months.
    Beyer J; Wolf E; Cordes U; Hassingen W
    Horm Metab Res Suppl; 1979; (8):127-31. PubMed ID: 395068
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Subcutaneous insulin order sets and protocols: effective design and implementation strategies.
    Maynard G; Wesorick DH; O'Malley C; Inzucchi SE;
    J Hosp Med; 2008 Sep; 3(5 Suppl):29-41. PubMed ID: 18951386
    [No Abstract]   [Full Text] [Related]  

  • 27. Timing of insulin delivery with meals.
    Kraegen EW; Chisholm DJ; McNamara ME
    Horm Metab Res; 1981 Jul; 13(7):365-7. PubMed ID: 7024077
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Glycemic control in insulin-dependent diabetes mellitus. Comparison of outpatient intensified conventional therapy with continuous subcutaneous insulin infusion.
    Reeves ML; Seigler DE; Ryan EA; Skyler JS
    Am J Med; 1982 Apr; 72(4):673-80. PubMed ID: 7041646
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Continuous blood glucose monitoring in insulin-treated diabetes.
    Mirouze J; Collard F; Selam JL; Pham J
    Horm Metab Res; 1977; Suppl 7():77-88. PubMed ID: 873445
    [No Abstract]   [Full Text] [Related]  

  • 30. Efficacy and safety of inhaled insulin (exubera) compared with subcutaneous insulin therapy in patients with type 2 diabetes: results of a 6-month, randomized, comparative trial.
    Hollander PA; Blonde L; Rowe R; Mehta AE; Milburn JL; Hershon KS; Chiasson JL; Levin SR
    Diabetes Care; 2004 Oct; 27(10):2356-62. PubMed ID: 15451900
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison between multi-injection and continuous subcutaneous insulin therapy in insulin-dependent diabetic inpatients.
    Saibene V; Melandri M; Brembilla L; Spotti D; Pozza G
    Acta Diabetol Lat; 1981; 18(1):45-50. PubMed ID: 7010856
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Insulin in the management of the diabetic surgical patient: continuous intravenous infusion vs subcutaneous administration.
    Taitelman U; Reece EA; Bessman AN
    JAMA; 1977 Feb; 237(7):658-60. PubMed ID: 576296
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Technological advancements in diabetes care.
    Christiano AS; Shessler EM
    Adolesc Med State Art Rev; 2010 Apr; 21(1):129-37, x. PubMed ID: 20568560
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term, ambulatory, subcutaneous insulin infusion versus multiple daily injections in brittle diabetic patients.
    Barbosa J; Menth L; Eaton J; Sutherland D; Freier EF; Najarian J
    Diabetes Care; 1981; 4(2):269-74. PubMed ID: 7011745
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [New insulins in diabetes therapy].
    Morell B
    Schweiz Med Wochenschr; 1979 Mar; 109(10):362-5. PubMed ID: 570723
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Management of severely brittle diabetes by continuous subcutaneous and intramuscular insulin infusions: evidence for a defect in subcutaneous insulin absorption.
    Pickup JC; Home PD; Bilous RW; Keen H; Alberti KG
    Br Med J (Clin Res Ed); 1981 Jan; 282(6261):347-50. PubMed ID: 6780019
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Clinical application and significance of drug delivery systems. Insulin injection therapy of diabetes].
    Iwaoka H; Tsuchida H; Makino H; Yoshida S
    Nihon Rinsho; 1989 Jun; 47(6):1329-34. PubMed ID: 2671444
    [No Abstract]   [Full Text] [Related]  

  • 38. Comparison of two twice-daily insulin regimens: ultralente/soluble and soluble/isophane.
    Ward GM; Simpson RW; Ward EA; Turner RC
    Diabetologia; 1981 Oct; 21(4):383-6. PubMed ID: 7026334
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Glucose homeostasis under continuous intravenous insulin therapy in diabetics.
    Hepp KD; Renner R; Funcke HJ; Mehnert H; Haerten R; Kresse H
    Horm Metab Res; 1977; Suppl 7():72-6. PubMed ID: 873444
    [No Abstract]   [Full Text] [Related]  

  • 40. Insulin delivery with meals. Plasma insulin profiles after bolus injection of human or porcine neutral insulin.
    Scott R; Smith J
    Diabete Metab; 1983; 9(2):95-9. PubMed ID: 6352353
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.